DEVELOPMENT, OPTIMIZATION AND IN VITRO CHARACTERIZATION OF HALOPERIDOL NANOCRYSTALS USING 32 FACTORIAL DESIGN
DOI:
https://doi.org/10.22159/ijap.2024v16i3.50412Keywords:
Haloperidol, Antipsychotic drug, BCS- II class of drugs, 32 factorial designAbstract
Objective: The main aim of the present study was to improve the dissolution rate of Haloperidol nanocrystals and thereby increase their bioavailability. Haloperidol is a typical antipsychotic drug and it is used to treat schizophrenia as well as acute mania and mixed states associated with bipolar disorder. Haloperidol falls into the Biopharmaceutics Classification System (BCS- II) class of drugs (poorly soluble aqueous and highly permeable) and has poor bioavailability.
Methods: The present study involves the preparation and optimization of Haloperidol nanocrystals by the anti-solvent precipitation method using Polaxomer407 and polyvinyl pyrrolidone K30 (PVP K30). The prepared nanocrystals were evaluated for various parameters like particle size, zeta potential, % drug content, % yield, surface morphology, drug-excipient compatibility studies (Fourier-transform infrared spectroscopy (FT-IR) and Differential Scanning Calorimetry (DSC)), and in-vitro dissolution studies.
Results: Nine preparations were done and the best preparation amongst them was selected for further studies. F7 preparation containingpolaxomer407 and PVP K30 was selected as optimized preparation based on their evaluation parameters. 32 factorial design was used in the preparation. The particle size of the F7 nanocrystals was 300.2±2.7 nm and the zeta potential -36.3±3.2 mV. The % yield was in the range of 63.62±0.3% -98.21±0.8 %. The drug content of various preparations was found to be in the range of 58.46±0.8% -93.54±0.5 %. In-vitro dissolution studies showed the highest % drug release for F7(91.54±0.03%) in 10 hrs.
Conclusion: F7 preparation was found to be having acceptable characteristics and thus selected as optimized preparation.
Downloads
References
Alankar S, Radhika A, Rishi PS, Rakhi K.A mini review on properties, mechanism of action, pharmacokinetic and pharmacodynamics and analytical methods of cariprazine. Int J App Pharm. 2023;15(1):31-5. doi:https://doi.org/10.22159/ijap.2023v15i1.46651
Florence AT, Attwood D. Drug absorption and routes of administration. In: Physicochemical principles of pharmacy. 4th ed. London: Pharmaceutical Press; 2006. Pg. 329–391.
Dressman JB, Thelen K, Jantratid E. Towards quantitative prediction of oral drug absorption. Clin Pharmacokinetic.2008;47(10):655–67.doi: 10.2165/00003088-200847100-00003
Sanjay B, Meena B. Nanocrystals: Current strategies and trends, Int J Res Pharm Biomed Sci. 2012;3(1):407-19.
Tunick MH, Van Hechen DL,Cook PH et. al., Transmission electron microscopy of mozzarella cheeses made frommicrofluidized milk. J Agricul Food Che. 2002;50:99-103. doi: 10.1021/jf010633c
Shegokar R, Müller RH. Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives. Int J Pharm. 2010;399:129-39.doi: 10.1016/j.ijpharm.2010.07.044
Dong Y. Preparation and characterization of spironolactone nanoparticles by antisolvent precipitation. Int J Pharm. 2009;375:84-8. Doi: 10.1016/j.ijpharm.2009.03.013
Douroumis D, Fahr A. Stable carbamazepine colloidal systems using the cosolvent technique. Eur J Pharm Sci. 2007;30:367-74. Doi: 10.1016/j.ejps.2006.12.003
Kumar V. Formulation and stability of itraconazole and odanacatib nanoparticles: governing physical parameters. Mol Pharm. 2009;6:1118-24. doi: 10.1021/mp900002t
Hu T. Engineering of drug nanoparticles by HGCP for pharmaceutical applications. Particuology. 2008;6:239-51.
Kakran M. Fabrication of drug nanoparticles by evaporative precipitation of nanosuspension. Int. J. Pharm. 2010;383:285-92.doi: 10.1016/j.ijpharm.2009.09.030
Tozuka Y. A combinational supercritical CO2 system for nanoparticle preparation of indomethacin. Int. J. Pharm. 2010;386:243-8. Doi: 10.1016/j.ijpharm.2009.10.044
De Waard H. Preparation of drug nanocrystals by controlled crystallization: Application of a 3-way nozzle to prevent premature crystallization for 1260large scale production. Eur. J. Pharm. Sci. 2009;38:224-229. DOI: 10.1016/j.ejps.2009.07.005
Tugba G, Neslihan RG, Leven T. Nanocrystal technology for oral delivery of poorly water-soluble drugs. FABAD J Pharm Sci. 2010;34:55–65.
Xia D. Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability. Eur. J. Pharm. Sci. 2010;40:325-34.doi: 10.1016/j.ejps.2010.04.006
Biswadip S, Rainer H, Muller. Bottom- up approaches for preparing drug nanocrystals: Formulations and factors affecting particle size. Int J Pharm. 2013;453(1):126-41.doi: 10.1016/j.ijpharm.2013.01.019
Liu et al., Drug nanocrystals: In vivo perfomances. J Cont Rel. 2012;160(3):418-30.doi: 10.1016/j.jconrel.2012.03.013
Anju G, Rupa M, Kamla P. Formulation, optimization and characterization of Ziprasidone nanocrystals prepared by media milling method. Int J Pharm Sci. 2015;7(8):146-50.
Lisha W, Yanxia J, Wei G, Zhenqiao K, Meng M, Aiping Z, Xiaoyan Z, Jianxu S. Preparation, physical characterization and pharmacokinetic study of paclitaxel nanocrystals. Drug Dev Industrial Pharm. 2014;41(8):1-10.doi: 10.3109/03639045.2014.950272
Bin D, Guopeg S, Dandan W. Development and characterization of glimepiride Nanocrystals formulation and evaluation of its pharmacokinetics in rats. Drug Del. 2013;20(1):25-33.doi: 10.3109/10717544.2012.742939
Arun K, Rajkumar M, Anil B. Design, development and evaluation of Nanocrystals of Valsartan for solubility enhancement. World J Pharm Pharm Sci. 2014;3(3):1414-27.
Sunny RS. Rajesh HP, Jayant RC, Navin RS. Glibenclamide nanocrystals for bioavailability enhancement: Formulation design, Process optimization, and pharmacodynamic evaluation. J Pharm Innov. 2014;9:227–37.doi: 10.1007/s12247-014-9189-y
Nur Alam A, Mahdi J, Abdul M, Fadlina CS. Celastrol nanoemulgel formulation and in vitro penetration test. Int J Pharm Sci. 12(8):82-91.doi: https://doi.org/10.22159/ijpps.2020v12i8.37167
Zahra B, Azade T, Shahla S. Formulation, optimization and characterization of gemfibrozil nanocrystals prepared by wet milling technique. Asian J Pharm. 2015;9:19-22.doi: 10.4103/0973-8398.150032
Tongying J, Ning H, Buwen Z, Yuling X, Siling W. Enhanced dissolution rate and oral bioavailability of simvastatin nanocrystal prepared by son precipitation, Drug Dev Ind Pharm. 2012;38(10):1230-9.Doi: 10.3109/03639045.2011.645830
Alhamhoom Y, Ravi G, Osmani RAM, Hani U, Gowrav MP. Formulation, Characterization, and Evaluation of Eudragit-Coated Saxagliptin Nanoparticles Using 3 Factorial Design Modules. Molecules. 2022;27:1-17.doi: 10.3390/molecules27217510
Paun JS, Tank HM. Screening of Formulating and Processing Parameters for Ziprasidone Hydrochloride Nanosuspension Prepared by Nanoprecipitation Ultrasonication Technique. J Pharm Sci Biosci Res. 2016;6(6):766-72.doi: 10.13286/j.1001-5213.2021.14.09
Gautham U, Anasuya P, Hemanth G. Formulation and evaluation of nanoparticle drug delivery system for treatment of hypertension. Int J App Pharm. 2023;15(6):90-97.doi: https://doi.org/10.22159/ijap.2023v15i6.48971
Garg S, Pareek, Pitliya P, Trivedi S, Puri D, Saini PCS, Ajay CS. Formulation and Evaluation of fast dissolving tablet of Ziprasidone HCl. Indo American J Pharm Res. 2013;3(5):3642-3651.
Bhujbal NS, Karthickeyan K. Formulation and Development of Nanocrystals by Using Natural Amino Acid. Eur. Chem. Bull. 2023;12(3):861-72. doi: 10.31838/ecb/2023.12.3.064
Dina L. Formulation and Evaluation of Nanocrystals of a Lipid Lowering Agent. Iranian Journal of Pharmaceutical Research. 2016;15(1):71-82.
Ravi G, Vishal GN. Development and evaluation of transdermal film containing solid lipid nanoparticles of rivastigmine tartrate. Int J App Pharm. 2017;9(6):85-90.doi: https://doi.org/10.22159/ijap.2017v9i6.22354
Aya ME, NagiaAEl-M, Hanan MEl-N. Formulation and evaluation of fast dissolving tablets of haloperidol solid dispersion. Saudi Med. J. 2022;30:1589-1602. doi: https://doi.org/10.1016/j.jsps.2022.09.002
Arvind Sharma, Alok Pal Jain, Sandeep Arora. Formulation and In-Vitro evaluation of Nanocrystal formulation of poorly soluble drugs. J Drug DelivTher. 2019; 9(4-s):1183-90. doi: https://doi.org/10.22270/jddt.v9i4-s.3873
Published
How to Cite
Issue
Section
Copyright (c) 2024 DAMINENI SARITHA, P. SUBHASH CHANDRA BOSE, RIYAZ ALI M. OSMANI, PADMINI IRIVENTI, SANDEEP KANNA, GUNDAWAR RAVI
This work is licensed under a Creative Commons Attribution 4.0 International License.